Antifungal effect of a new photosensitizer derived from BODIPY on Candida albicans biofilms

Photodiagnosis Photodyn Ther. 2022 Sep:39:102946. doi: 10.1016/j.pdpdt.2022.102946. Epub 2022 Jun 1.

Abstract

Background: Photodynamic therapy (PDT) may be an alternative treatment of Candida albicans (C. albicans) infections. The aim of this study was to investigate the antifungal effect of PDT mediated by a new photosensitizer (PS) derived from BODIPY (BDP-4L) on C. albicans biofilms.

Methods: C. albicans biofilms were incubated with BDP-4L of different concentrations and then irradiated at the light doses of 1.8, 3.6, 5.4, 7.2 and 9.0 J/cm2. XTT reduction assay was conducted to determine the PS concentration and PDT parameters. Confocal light scanning microscopy (CLSM) and scanning electron microscope (SEM) were used to visualize and quantify the effect of BDP-4L on C. albicans biofilms after PDT.

Results: C. albicans biofilms were inactivated in light dose-dependent and PS concentration-dependent manners using BDP-4L as PS. Without irradiation, no inactivation effect was observed when PS concentrations varied from 5 μM to 80 μM. 40 μM PS with 3.6 J/cm2 irradiation resulted in a significant reduction of 83.8% in biofilm metabolic activities. CLSM assay demonstrated that cell viability was obviously inhibited by 82.6%. SEM images revealed ruptured and rough cell surface, indicating increased cell membrane permeability after PDT.

Conclusions: Our results suggested that BDP-4L mediated PDT exhibited a favorable antifungal effect on C. albicans biofilms.

Keywords: BODIPY; Biofilm; Candida albicans; Photodynamic therapy.

MeSH terms

  • Antifungal Agents / pharmacology
  • Biofilms
  • Boron Compounds
  • Candida albicans
  • Candidiasis*
  • Photochemotherapy* / methods
  • Photosensitizing Agents / pharmacology

Substances

  • 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene
  • Antifungal Agents
  • Boron Compounds
  • Photosensitizing Agents